<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2199-2-10.anc" start="25079" end="25090" sStart="-1" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" text="The CAS peptide was &lt;b&gt;transferred&lt;/b&gt; to pLexA as follows: Two complementary oligos which encoded the 11 amino acid CAS peptide (oVT2899: AATTCTGGAGCTTCTGGATCCAAGAATGGAATCAAAGTTAAG, and oVT2900: GGCCGCTTAACTTTGATTCCATTCTTGGATCCAGAAGCTCCAG) were annealed in PCR buffer and cloned using standard methods into pVT725 via EcoRI and NotI restriction sites." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2199-2-10.anc" start="13720" end="13731" sStart="null" offset="0" sid="null" wn="4" wnkey="transfer%2:38:00::" text="One sequence (B42), 72 residues long, was shown to function as an activator when &lt;b&gt;transferred&lt;/b&gt; to the lexA DNA binding domain." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2199-2-10.anc" start="25772" end="25783" sStart="null" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" text="Transformants were then pooled and &lt;b&gt;transferred&lt;/b&gt; onto plates lacking histidine and leucine in order to select for peptide sequences capable of activating the lexA-operator-driven LEU2 reporter." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-10.anc" start="10558" end="10565" sStart="null" offset="24" sid="r8.suggest.v.0168" wn="3" wnkey="suggest%2:32:02::" text="Together, these results suggest that translation of the +1 frame of GFP, after the random peptide insert, results in a molecule with activator properties." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2199-2-10.anc" start="14912" end="14919" sStart="null" offset="0" sid="null" wn="3" wnkey="success%1:26:00::" text="In addition, the &lt;b&gt;success&lt;/b&gt; of the yeast two-hybrid technique suggests that the geometric constraints on transactivation are not severe (i.e." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2199-2-10.anc" start="14912" end="14919" sStart="null" offset="0" sid="null" wn="2" wnkey="success%1:04:00::" text="In addition, the &lt;b&gt;success&lt;/b&gt; of the yeast two-hybrid technique suggests that the geometric constraints on transactivation are not severe (i.e." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2199-2-10.anc" start="14912" end="14919" sStart="null" offset="0" sid="null" wn="1" wnkey="success%1:11:00::" text="In addition, the &lt;b&gt;success&lt;/b&gt; of the yeast two-hybrid technique suggests that the geometric constraints on transactivation are not severe (i.e." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-10.anc" start="15037" end="15043" sStart="null" offset="142" sid="r11.severe.j.0300" wn="4" wnkey="severe%5:00:02:nonindulgent:00" text="In addition, the success of the yeast two-hybrid technique suggests that the geometric constraints on transactivation are not severe (i.e." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2199-2-10.anc" start="9663" end="9667" sStart="null" offset="0" sid="null" wn="1" wnkey="rate%1:28:00::" text="Based on their frequency in the non-selected library, stop codons were expected at a &lt;b&gt;rate&lt;/b&gt; of 27%." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2199-2-10.anc" start="5937" end="5941" sStart="null" offset="0" sid="null" wn="4" wnkey="rate%1:24:00::" text="The reversion &lt;b&gt;rate&lt;/b&gt; for the assay was low (&lt; 0.001%)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2199-2-10.anc" start="9663" end="9667" sStart="null" offset="0" sid="null" wn="4" wnkey="rate%1:24:00::" text="Based on their frequency in the non-selected library, stop codons were expected at a &lt;b&gt;rate&lt;/b&gt; of 27%." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2199-2-10.anc" start="5937" end="5941" sStart="null" offset="0" sid="null" wn="4" wnkey="rate%1:24:00::" text="The reversion &lt;b&gt;rate&lt;/b&gt; for the assay was low (&lt; 0.001%)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-10.anc" start="5484" end="5494" sStart="null" offset="62" sid="r10.particular.j.0292" wn="1" wnkey="particular%5:00:00:specific:00" text="7 residues, with no discernible bias for or against particular amino acids (Table 1)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-10.anc" start="5999" end="6005" sStart="null" offset="23" sid="r8.number.n.0367" wn="1" wnkey="number%1:07:00::" text="Based on the number of colonies per plate, frequencies of 0.02% of activating peptides in the lexA-GFP/peptide library and 0.1% in the C-terminal library were calculated." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2199-2-10.anc" start="14507" end="14511" sStart="null" offset="0" sid="null" wn="2" wnkey="long%3:00:01::" text="screened for C-terminal Gal4BD peptides, 8 amino acids &lt;b&gt;long&lt;/b&gt;." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2199-2-10.anc" start="13663" end="13667" sStart="null" offset="0" sid="null" wn="2" wnkey="long%3:00:01::" text="One sequence (B42), 72 residues &lt;b&gt;long&lt;/b&gt;, was &lt;b&gt;shown&lt;/b&gt; to function as an activator when transferred to the lexA DNA binding domain." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2199-2-10.anc" start="14507" end="14511" sStart="null" offset="0" sid="null" wn="2" wnkey="long%3:00:01::" text="screened for C-terminal Gal4BD peptides, 8 amino acids &lt;b&gt;long&lt;/b&gt;." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2199-2-10.anc" start="14507" end="14511" sStart="null" offset="0" sid="null" wn="2" wnkey="long%3:00:01::" text="screened for C-terminal Gal4BD peptides, 8 amino acids &lt;b&gt;long&lt;/b&gt;." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2199-2-10.anc" start="14507" end="14511" sStart="null" offset="0" sid="null" wn="2" wnkey="long%3:00:01::" text="screened for C-terminal Gal4BD peptides, 8 amino acids &lt;b&gt;long&lt;/b&gt;." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2199-2-10.anc" start="14507" end="14511" sStart="null" offset="0" sid="null" wn="2" wnkey="long%3:00:01::" text="screened for C-terminal Gal4BD peptides, 8 amino acids &lt;b&gt;long&lt;/b&gt;." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2199-2-10.anc" start="14507" end="14511" sStart="null" offset="0" sid="null" wn="2" wnkey="long%3:00:01::" text="screened for C-terminal Gal4BD peptides, 8 amino acids &lt;b&gt;long&lt;/b&gt;." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2199-2-10.anc" start="14507" end="14511" sStart="null" offset="0" sid="null" wn="2" wnkey="long%3:00:01::" text="screened for C-terminal Gal4BD peptides, 8 amino acids &lt;b&gt;long&lt;/b&gt;." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-10.anc" start="4629" end="4635" sStart="null" offset="75" sid="r9.level.n.0887" wn="1" wnkey="level%1:07:00::" text="At least some of these truncated products were expressed at high levels in yeast when fused to lexA (Caponigro, unpublished)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-10.anc" start="10170" end="10173" sStart="null" offset="26" sid="r9.hit.v.0799" wn="4" wnkey="hit%2:38:00::" text="Both the +1 and -1 frames hit stop codons in GFP within 10 amino acids of the random peptide sequence." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-10.anc" start="22241" end="22245" sStart="null" offset="74" sid="r10.high.j.0315" wn="1" wnkey="high%3:00:02::" text="Peptide activators are recovered from random peptide libraries at high frequency." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-10.anc" start="12742" end="12751" sStart="null" offset="127" sid="r11.function.n.0923" wn="2" wnkey="function%1:07:00::" text="showed that fragments of the Gal4 activation region between 17 and 41 amino acids in length provide activation functions of a magnitude in rough proportion to their length [ 24 ] . This result suggests that short sequences are capable of stimulating transcription when complexed with promotor elements and that their effect is amplified by increasing the total content of such short sequences." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-10.anc" start="16083" end="16087" sStart="null" offset="15" sid="r9.fold.v.0451" wn="2147483645" wnkey="null" text="[ 21 ] . The 5-fold lower frequency of activators in the lexA-GFP/peptide library may indicate a role for the C-terminal negative charge, the specific geometry, or the conformational flexibility of the fused (vs." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-10.anc" start="8431" end="8435" sStart="null" offset="83" sid="r9.fold.v.0403" wn="2147483645" wnkey="null" text="If the C-terminal negative charge was included, the disparity was over 6-fold." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-10.anc" start="20025" end="20034" sStart="null" offset="52" sid="r8.1.different.j.0076" wn="1" wnkey="different%3:00:00::" text="Isolation of a panel of small peptides with different structural properties could improve the performance of the system by providing an option for multiple screens using a variety of peptides." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-10.anc" start="20025" end="20034" sStart="null" offset="52" sid="r8.1.different.j.0076" wn="1" wnkey="different%3:00:00::" text="Isolation of a panel of small peptides with different structural properties could improve the performance of the system by providing an option for multiple screens using a variety of peptides." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-10.anc" start="20025" end="20034" sStart="null" offset="52" sid="r8.1.different.j.0076" wn="1" wnkey="different%3:00:00::" text="Isolation of a panel of small peptides with different structural properties could improve the performance of the system by providing an option for multiple screens using a variety of peptides." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-10.anc" start="20025" end="20034" sStart="null" offset="52" sid="r8.1.different.j.0076" wn="1" wnkey="different%3:00:00::" text="Isolation of a panel of small peptides with different structural properties could improve the performance of the system by providing an option for multiple screens using a variety of peptides." />
  </sentences>
</list>